心血管疾病中翻译后修饰的细胞和分子生物学
Li Zhu1, Yong-Ping Liu2, Yu-Ting Huang3
1Graduate School of Dalian Medical University, Dalian 116000, Liaoning, China; State Key Laboratory of Frigid Zone Cardiovascular Disease, Department of Cardiovascular Surgery, General Hospital of Northern Theater Command, Shenyang 110016, Liaoning, China.
心血管疾病 (CVD) 涉及复杂的机制. 本综述探讨了心血管疾病发病的翻译后修改,并讨论了潜在的治疗策略的基因组脱乙酶 (HDAC) 抑制剂.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,对其发病机制的了解不完全.
- 蛋白质组学揭示了翻译后修饰 (PTMs) 在关键心血管疾病过程 (如细胞亡,新陈代谢和氧化应激) 中的参与.
研究的目的:
- 对心血管疾病中PTMs的当前知识进行审查.
- 突出新的PTM,如化和化.
- 总结一下用于心血管疾病治疗的基因素脱乙酶 (HDAC) 抑制剂.
主要方法:
- 文献综述,重点关注心血管疾病中的蛋白质组学和PTM.
- 对新型PTM (糖化,化) 的研究分析.
- 在心血管疾病治疗中使用的HDAC抑制剂的数据汇编.
主要成果:
- 在各种心血管疾病的发病过程中,PTMs起着至关重要的作用.
- 新兴的PTM如化和化提供了新的见解.
- HDAC 抑制剂代表了对心血管疾病的有希望的治疗途径.
结论:
- 了解PTM对于阐明心血管疾病的发病过程至关重要.
- 新型PTM和HDAC抑制剂为心血管疾病治疗和未来研究提供了新的视角.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
09:43Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
相关概念视频
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pathophysiology of Cardiac Performance
Regulation of Expression at Multiple Steps
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
